NeuroOne receives Nasdaq delisting notice for bid price below $1.00 for 30 days

NEUROONE MEDICAL TECHNOLOGIES Corp

Closing bid price of common stock below $1.00 for 30 consecutive business days triggered Nasdaq minimum bid price deficiency.
Company has 180 calendar days, until January 7, 2025, to regain compliance by closing at $1.00+ for 10 consecutive days.
If not compliant by Jan 7, 2025, may qualify for an additional 180-day period if it meets other listing standards.
NeuroOne intends to monitor bid price and consider available options to cure the deficiency; delisting risk remains if not cured.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.